|
IKNA
|
Ikena Oncology, Inc.
|
US
|
NASDAQ
|
|
KRON
|
Kronos Bio, Inc.
|
US
|
NASDAQ
|
|
KTRA
|
Kintara Therapeutics, Inc.
|
US
|
NASDAQ
|
|
MGNX
|
MacroGenics, Inc.
|
US
|
NASDAQ
|
|
PPBT
|
Purple Biotech Ltd.
|
US
|
NASDAQ
|
|
SLS
|
SELLAS Life Sciences Group, Inc.
|
US
|
NASDAQ
|
|
SURF
|
Surface Oncology, Inc.
|
US
|
NASDAQ
|
|
LYTIX
|
Lytix Biopharma AS
|
NO
|
OL
|
|
IMMU
|
Immunicum AB (publ)
|
SE
|
ST
|
|
MDG1
|
Medigene AG
|
DE
|
XETRA
|
|
AVCTF
|
Avacta Group Plc
|
US
|
OTC
|
|
PQ6
|
Starpharma Holdings Limited
|
DE
|
F
|
|
PQ6A
|
STARPHARMA HLDG.SP.ADR/10
|
DE
|
F
|
|
RXK3
|
SELLAS Life Sciences Group Inc
|
DE
|
F
|
|
SPL
|
Starpharma Holdings Ltd
|
AU
|
AU
|